Nomura Holdings’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Nomura Holdings’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-85,648	Closed	-$360K	–	1763
2023 Q1	$360K	Sell	85,648 -80,974	-49%	-$420K	﹤0.01%	1179
2022 Q4	$997K	Buy	166,622 +165,612	+16,397%	+$904K	﹤0.01%	853
2022 Q3	$6K	Buy	+1,010	New	+$6.29K	﹤0.01%	1571
2015 Q4	–	Sell	-2,400	Closed	-$38K	–	2274
2015 Q3	$38K	Buy	+2,400	New	+$41.5K	﹤0.01%	1561
2014 Q2	–	Sell	-2,943	Closed	-$100K	–	3301
2014 Q1	$100K	Buy	+2,943	New	+$101K	﹤0.01%	2505
2013 Q4	–	Sell	-1,075	Closed	-$17K	–	2644
2013 Q3	$17K	Sell	1,075 -3,870	-78%	-$44.8K	﹤0.01%	2186
2013 Q2	$53K	Buy	+4,945	New	+$58K	﹤0.01%	2069

Other funds holding CTIC

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Nomura Holdings's CTIC Position: Q2 2023 in Review

Nomura Holdings sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 85,648 shares — an estimated $360K sold.

Nomura Holdings first reported a position in CTIC in Q2 2013 and held it in 7 quarters. The position peaked at $997K in Q4 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Nomura Holdings reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Nomura Holdings sold 85,648 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $360K.
Nomura Holdings first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 7 quarters.
Nomura Holdings's CTI BioPharma Corp. (DE) Common Stock position peaked at $997K in Q4 2022.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Nomura Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.